Form 8-K - Current report:
SEC Accession No. 0000886163-16-000136
Filing Date
2016-02-10
Accepted
2016-02-10 16:04:50
Documents
3
Period of Report
2016-02-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ligand-8xkq415earningsrele.htm 8-K 17584
2 EXHIBIT 99.1 q42015earningsrelease10k.htm EX-99.1 249262
3 ligandlogoa07.jpg GRAPHIC 36525
  Complete submission text file 0000886163-16-000136.txt   318383
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 161405743
SIC: 2834 Pharmaceutical Preparations